Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Y-3 in Chinese Subjects With Acute Ischemic Stroke
NCT06517173Phase 3Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jul 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of loberamisal in ischemic stroke, sponsored by Beijing Tiantan Hospital. Started Jul 2024; status: completed.
02
Drugs
loberamisal
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06517173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06517173.